References
Aouizerat, B., Dodd, M., Lee, K., West, C., Paul, S., Cooper, B., … Miaskowski, C. (2009). Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biological Research for Nursing, 11, 27-41.
http://dx.doi.org/10.1177/1099800409333871
Au, W. Y., Fung, A., Wong, K. F., Chan, C. H., & Liang, R. (2006). Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leukemia and Lymphoma, 47, 2189-2193
http://dx.doi.org/10.1080/10428190600758645
Bel Hadj Jrad, B., Chatti, A., Laatiri, A., Ahmed, S. B., Romdhane, A., Ajimi, S., & Chouchane, L. (2007). Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. European Journal of Haematology, 78, 117-122.
http://dx.doi.org/10.1111/j.1600-0609.2006.00784.x
Belluco, C., Olivieri, F., Bonafe, M., Giovagnetti, S., Mammano, E., Scalerta, R., … Lise, M. (2003). 174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clinical Cancer Research, 9, 2173-2176.
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64, 604-611.
Cerhan, J. R., Liu-Mares, W., Fredericksen, Z. S., Novak, A. J., Cunningham, J. M., Kay, N. E., … Slager, S. L. (2008). Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers and Prevention, 17, 3161-3169.
http://dx.doi.org/10.1158/1055-9965.EPI-08-0536
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., … Lee, B. N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919-2925.
http://dx.doi.org/10.1002/cncr.11382
Cox, E. D., Hoffmann, S. C., DiMercurio, B. S., Wesley, R. A., Harlan, D. M., Kirk, A. D., & Blair, P. J. (2001). Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 72, 720-726.
Duarte, I., Santos, A., Sousa, H., Catarino, R., Pinto, D., & Matos, A. (2005). G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochemical Biophysical Research Communications, 334, 588-592.
http://dx.doi.org/10.1016/j.bbrc.2005.06.137
Fayad, L., Cabanillas, F., Talpaz, M., McLaughlin, P., & Kurzrock, R. (1998). High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma. Leukemia and Lymphoma, 30, 563-571.
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., & Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376.
http://dx.doi.org/10.1172/JCI2629
Guo, W., Wang, N., Li, Y., & Zhang, J. H. (2005). Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chinese Medical Journal (English), 118, 1870-1878.
Hegedus, C. M., Skibola, C. F., Bracci, P., Holly, E. A., & Smith, M. T. (2007). Screening the human serum proteome for genotype-phenotype associations: An analysis of the IL6 -174G>C polymorphism. Proteomics, 7, 548-557.
http://dx.doi.org/10.1002/pmic.200600366
Heitkemper, M., Levy, R., Jarrett, M., & Bond, E. F. (1995). Interventions for irritable bowel syndrome: A nursing model. Gastroenterology Nursing, 18, 224-230.
Heitkemper, M., & Shaver, J. (1989). Nursing research opportunities in enteral nutrition. Nursing Clinics of North America, 24, 415-426.
Hinds, P. S., Hockenberry, M., Rai, S. N., Zhang, L., Razzouk, B. I., Cremer, L., … Rodriguez-Galindo, C. (2007). Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. Journal of Pain and Symptom Management, 33, 686-697.
Hinds, P. S., Hockenberry, M., Rai, S. N., Zhang, L., Razzouk, B. I., McCarthy, K., … Rodriguez-Galindo, C. (2007). Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncology Nursing Forum, 34, 393-402.
http://dx.doi.org/10.1188/07.ONF.393-402
Hinds, P. S., Hockenberry, M. J., Gattuso, J. S., Srivastava, D. K., Tong, X., Jones, H., … Pui, C. H. (2007). Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer, 110, 2321-2330.
http://dx.doi.org/10.1002/cncr.23039
Hinds, P. S., Hockenberry-Eaton, M., Gilger, E., Kline, N., Burleson, C., Bottomley, S., & Quargnenti, A. (1999). Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients. Cancer Nursing, 22, 277-288.
Hoffmann, S. C., Stanley, E. M., Cox, E. D., Craighead, N., DiMercurio, B. S., Koziol, D. E., … Blair, P. J. (2001). Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation, 72, 1444-1450.
Hoffmann, S. C., Stanley, E. M., Cox, E. D., DiMercurio, B. S., Koziol, D. E., Harlan, D. M., … Blair, P. J. (2002). Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation, 2, 560-567.
http://dx.doi.org/10.1034/j.1600-6143.2002.20611.x
Hong, S., Mills, P. J., Loredo, J. S., Adler, K. A., & Dimsdale, J. E. (2005). The association between interleukin-6, sleep, and demographic characteristics. Brain, Behavior, and Immunity, 19, 165-172.
http://dx.doi.org/10.1016/j.bbi.2004.07.008
Jeanmonod, P., von Kanel, R., Maly, F. E., & Fischer, J. E. (2004). Elevated Plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha -308 G/A polymorphism. Psychosomatic Medicine, 66, 501-506.
Kurzrock, R. (1997). Cytokine deregulation in hematological malignancies: Clinical and biological implications. Clinical Cancer Research, 3(12, Pt. 2), 2581-2584.
Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., … Cleeland, C. S. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11, 279-292.
http://dx.doi.org/10.1159/000079408
Littell, R. (2006). SAS for mixed models. Cary, NC: SAS Institute, Inc.
Meeske, K. A., Siegel, S. E., Globe, D. R., Mack, W. J., & Bernstein, L. (2005). Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. Journal of Clinical Oncology, 23, 5501-5510.
http://dx.doi.org/10.1159/000079408
Pelayo, R. P., Thorpy, M. J., & Glovinsky, P. (1988). Prevalence of delayed sleep phase syndrome among adolescents. Sleep Research, 17, 391.
Rich, T., Innominato, P. F., Boerner, J., Mormont, M. C., Iacobelli, S., Baron, B., & Levi, F. (2005). Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research, 11, 1757-1764.
http://dx.doi.org/10.1158/1078-0432.CCR-04-2000
Riha, R. L., Brander, P., Vennelle, M., McArdle, N., Kerr, S. M., Anderson, N. H., & Douglas, N. J. (2005). Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnea-hypopnoea syndrome. European Respiratory Journal, 26, 673-678.
http://dx.doi.org/10.1183/09031936.05.00130804
Sadeh, A., Sharkey, K. M., & Carskadon, M. A. (1994). Activity-based sleep-wake identification: An empirical test of methodological issues. Sleep, 17, 201-207.
Schiller, J. H., Storer, B. E., Witt, P. L., Alberti, D., Tombes, M. B., Arzoomanian, R., … Voss, S. D. (1991). Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Research, 51, 1651-1658.
Schubert, C., Hong, S., Natarajan, L., Mills, P. J., & Dimsdale, J. E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior and Immunity, 21, 413-427.
http://dx.doi.org/10.1016/j.bbi.2006.11.004
Vgontzas, A. N., Bixler, E. O., Lin, H. M., Prolo, P., Trakada, G., & Chrousos, G. P. (2005). IL-6 and its circadian secretion in humans. Neuroimmunomodulation, 12, 131-140.
http://dx.doi.org/10.1159/000084844
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Lotsikas, A., Zachman, K., Kales, A., … Chrousos, G. P. (1999). Circadian interleukin-6 secretion and quantity and depth of sleep. Journal of Clinical Endocrinology and Metabolism, 84, 2603-2607.
Vgontzas, A. N., Zoumakis, E., Bixler, E. O., Lin, H. M., Follett, H., Kales, A., & Chrousos, G. P. (2004). Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. Journal of Clinical Endocrinology and Metabolism, 89, 2119-2126.
Vgontzas, A. N., Zoumakis, E., Lin, H. M., Bixler, E. O., Trakada, G., & Chrousos, G. P. (2004). Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. Journal of Clinical Endocrinology and Metabolism, 89, 4409-4413.
Wang, S. S., Cerhan, J. R., Hartge, P., Davis, S., Cozen, W., Severson, R. K., … Rothman, N. (2006). Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Research, 66, 9771-9780.
http://dx.doi.org/10.1158/0008-5472.CAN-06-0324
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195-3199.
Wood, L. J., Nail, L. M., Gilster, A., Winters, K. A., & Elsea, C. R. (2006). Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncology Nursing Forum, 33, 535-542.
http://dx.doi.org/10.1188/06.ONF.535-542